---
name: ARSI Canada Inc
slug: arsicanada
site: both
website_domain: arsicanada.com
summary: ARSI Canada is a specialized CRO offering custom synthesis, API scale-up, analytical method development, and drug development services with over 50 years of combined experience and a GMP manufacturing facility in Bangladesh. Headquartered in Mississauga, Canada.
tagline: Custom synthesis, API scale-up, and analytical development with 50+ years of pharmaceutical expertise.
founded_year: 
employee_count_band: 51-200
employee_count_label: 51–200
parent_name: 
parent_slug: 
hq_country: CA
tier2_domain_verified: false
updated_at: 2026-06-15T07:00:42.980Z
services_count: 9
modalities_count: 1
indications_count: 0
locations_count: 2
review_signal_gate: closed
generated_by: BioBM Editorial AI
---

# ARSI Canada Inc

Custom synthesis, API scale-up, and analytical development with 50+ years of pharmaceutical expertise.

Listed on cdmo.directory.

## Summary

ARSI Canada is a specialized CRO offering custom synthesis, API scale-up, analytical method development, and drug development services with over 50 years of combined experience and a GMP manufacturing facility in Bangladesh. Headquartered in Mississauga, Canada.

## At a glance

- Employees (est.): 51–200
- HQ country: CA

## Services

- CMC Regulatory Submission Support
- Quality Control Testing
- Stability Testing & Storage
- Technology Transfer
- Process Development
- Analytical Method Development & Validation
- CMC Analytical Development
- Small Molecule Development & Manufacturing
- API Synthesis & Manufacturing

## Modalities

- Small Molecule

## Locations

- GMP Manufacturing, Bangladesh, Bangladesh
- Headquarters & R&D, Mississauga, Ontario, Canada

## Long description

## Overview

ARSI Canada Inc is a premier North American Contract Research Organization (CRO) with over 50 years of cumulative experience in pharmaceutical research, drug discovery, and development. The organization serves the pharmaceutical, biotechnology, medical device, diagnostics, agrochemicals, and academic research sectors.

## Core Services

### Custom Synthesis & Scale-Up
- Custom synthesis of complex small molecules, APIs, and intermediates from milligram to kilogram scales
- Pre-clinical and pilot-scale manufacturing with process development and route optimization
- Synthesis of reference standards, impurity standards, and specialty reagents (including peptides and radiopharmaceuticals)
- Full analytical results and Certificate of Analysis (CoA) for all compounds

### Analytical & Method Development
- Analytical method development and validation using chromatography and spectroscopy
- Structure elucidation via NMR, MS, and IR
- Forced degradation studies aligned with ICH guidelines
- Quality control and analytical verification at each scale-up phase

### Drug Development Support
- Route development and lead optimization
- Process development and engineering with Design of Experiments (DoE) approach
- Technology transfer and process validation
- Regulatory guidance aligned with GMP standards and ICH guidelines

### Manufacturing Capabilities
- R&D facility in Mississauga for non-GMP synthesis (mg to kg scale)
- GMP bulk manufacturing facility in Bangladesh with six 3000L reactors, multiple centrifuge machines, over 250 kg fluid bed dryers, and 250 MT annual capacity for GMP APIs and non-GMP intermediates
- 2000+ in-stock catalogue compounds for accelerated research

## Operational Metrics
- 50+ professional staff and collaborators
- 99% client satisfaction rate
- 97% on-time project delivery
- 430+ tests completed
- Emphasis on quality, speed, flexibility, and data-driven decision-making

_Profile last updated: 2026-06-15T07:00:42.980Z. Profile facts may include AI-assisted enrichment._

Auto-generated by BioBM Editorial AI for machine-readable profile access.